Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank

被引:109
作者
Fisher, MB
VandenBranden, M
Findlay, K
Burchell, B
Thummel, KE
Hall, SD
Wrighton, SA
机构
[1] Eli Lilly & Co, Lilly Res Labs, Dept Drug Disposit, Indianapolis, IN 46285 USA
[2] Univ Dundee, Ninewells Hosp & Med Sch, Dept Mol & Cellular Pathol, Dundee DD1 9SY, Scotland
[3] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA
[4] Indiana Univ, Sch Med, Dept Med, Div Clin Pharmacol,Wishard Mem Hosp, Indianapolis, IN USA
来源
PHARMACOGENETICS | 2000年 / 10卷 / 08期
关键词
glucuronidation; interindividual variability; tissue distribution; first pass metabolism;
D O I
10.1097/00008571-200011000-00007
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The variability in a liver bank and tissue distribution of three probe UDP-glucuronosyltransferase (UGT) activities were determined as a means to predict interindividual differences in expression and the contribution of extrahepatic metabolism to presystemic and systemic clearance. Formation rates of acetaminophen-O-glucuronide (APAPG), morphine-3-glucuronide (M3G), and oestradiol-3-glucuronide (E3G) as probes for UGT1A6, 2B7, and 1A1, respectively, were determined in human kidney, liver, and lung microsomes, and in microsomes from intestinal mucosa corresponding to duodenum, jejunum and ileum. While formation of E3G and APAPG were detectable in human kidney microsomes, M3G formation rates from kidney microsomes approached the levels seen in liver, indicating significant expression of UGT2B7. Interestingly, rates of E3G formation in human intestine exceeded the hepatic rates by several fold, while APAPG and M3G formation rates were low, The intestinal apparent K-m value for E3G formation was essentially identical to that seen in liver, consistent with intestinal UGT1A1 expression. No UGT activities were observed in lung. Variability in APAPG and M3G activity across a bank of 20 human livers was modest (less than or equal to 7-fold), compared to E3G formation, which varied approximately 30-fold. The E3G formation rates were found to segregate by UGT1A1 promoter genotype, with wild-type (TA)(6) rates significantly greater than homozygous mutant (TA)(7) individuals. Kinetic analyses were performed to demonstrate that the promoter mutation altered apparent V-max without significantly affecting apparent K-m. These results suggest that glucuronidation, and specifically UGT1A1 activity, can profoundly contribute to intestinal first pass metabolism and interindividual variability due to the expression of common allelic variants, Pharmacogenetics 10:727-739 (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:727 / 739
页数:13
相关论文
共 48 条
  • [1] The monkey and human uridine diphosphate-glucuronosyltransferase UGT1A9, expressed in steroid target tissues, are estrogen-conjugating enzymes
    Albert, C
    Vallée, M
    Beaudry, G
    Bélanger, A
    Hum, DW
    [J]. ENDOCRINOLOGY, 1999, 140 (07) : 3292 - 3302
  • [2] BACK D J, 1987, Alimentary Pharmacology and Therapeutics, V1, P339
  • [3] BAILEY MJ, 1996, J PHARM TOXICOL METH, V41, P27
  • [4] Cooperative ligand binding by bovine phenol sulfotransferase
    Beckmann, JD
    Henry, T
    Ulphani, J
    Lee, P
    [J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1998, 109 (1-3) : 93 - 105
  • [5] Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter:: A balanced polymorphism for regulation of bilirubin metabolism?
    Beutler, E
    Gelbart, T
    Demina, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (14) : 8170 - 8174
  • [6] Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases
    Bock, KW
    Gschaidmeier, H
    Heel, H
    Lehmköster, T
    Münzel, PA
    Bock-Hennig, BS
    [J]. DRUG METABOLISM REVIEWS, 1999, 31 (02) : 411 - 422
  • [7] PARACETAMOL GLUCURONIDATION BY RECOMBINANT RAT AND HUMAN PHENOL UDP-GLUCURONOSYLTRANSFERASES
    BOCK, KW
    FORSTER, A
    GSCHAIDMEIER, H
    BRUCK, M
    MUNZEL, P
    SCHARECK, W
    FOURNELGIGLEUX, S
    BURCHELL, B
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) : 1809 - 1814
  • [8] HUMAN UDP-GLUCURONOSYL TRANSFERASES - CHEMICAL DEFENSE, JAUNDICE AND GENE-THERAPY
    BRIERLEY, CH
    BURCHELL, B
    [J]. BIOESSAYS, 1993, 15 (11) : 749 - 754
  • [9] Molecular genetic basis of Gilbert's syndrome
    Burchell, B
    Hume, R
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 14 (10) : 960 - 966
  • [10] DISTRIBUTION OF UDP-GLUCURONOSYLTRANSFERASE AND ITS ENDOGENOUS SUBSTRATE URIDINE 5'-DIPHOSPHOGLUCURONIC ACID IN HUMAN TISSUES
    CAPPIELLO, M
    GIULIANI, L
    PACIFICI, GM
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (04) : 345 - 350